CXCL13

CXCL13 Informations sur la molécule

Nom anglais	C-X-C motif chemokine 13	Nombre de médicaments commercialisés	0
Nombre de médicaments cliniques	0	Alias de la cible	BCA-1，B cell-attracting chemokine 1
Phase de R&D la plus avancée	Preclinical

Nom anglais	C-X-C motif chemokine 13
Alias de la cible	BCA-1，B cell-attracting chemokine 1
Nombre de médicaments commercialisés	0
Nombre de médicaments cliniques	0
Phase de R&D la plus avancée	Preclinical

CXCL13 Liste de produits

Attribut
Protein (1)
Bibliothèque de produits
En ligne (1)
Espèces
Human (1)
Étiquette
His Tag (1)
Marqueur
Unconjugated (1)

Numéro de produit	Espèces	Système d'expression	Description du produit	Structure protéique	Pureté	Caractéristiques	Pré-commande/Commande
CX3-H1249	Human	E. coli	Human CXCL13 / BCA-1 Protein, His Tag				Ajouter au panier

Quantité totale1

CXCL13Contexte de la molécule

CXCL13, originally known as BLC (B-lymphocyte chemoattractant) or BCA-1 (B cell-attracting chemokine 1), is a homeostatic chemokine. It is constitutively secreted by stromal cells in B-cell areas of secondary lymphoid tissues (follicles), such as spleen, lymph nodes, tonsils, and Peyer's patches. CXCL13 plays a key role in orchestrating cell migration within spatially distinct regions of the secondary lymphoid organs. It strongly attracts B lymphocytes while promoting migration of only small numbers of T cells and macrophages. CXCL13 exerts its functions through its receptor CXCR5, which initially, was isolated from Burkitt Lymphoma and therefore designated as Burkitt's lymphoma receptor 1 (BLR1).

CXCL13Alias de la molécule

C-X-C motif chemokine 13,Angie,B cell-attracting chemokine 1,BCA-1,B lymphocyte chemoattractant,CXC chemokine BLC,Small-inducible cytokine B13,CXCL13,BCA1,BLC,SCYB13